BLEPH 10 DPS DIN 00001287
Health Canada record
| Active ingredient(s) | SULFACETAMIDE SODIUM 10 % |
|---|---|
| Dosage form | Drops |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01AB04 SULFACETAMIDE |
| Original market date | 31-Dec-1964 |
| Current status date | 04-Aug-2011 |
| Source | Health Canada DPD |
Establishment licence of the holder
Allergan Sales, LLC — licence , not currently licensed, last inspection rating C (2025-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SULFACETAMIDE SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00772313 | BALSULPH OPH LIQ 10.0% | BAUSCH & LOMB CANADA INC. | Drops | SULFACETAMIDE SODIUM 100 MG | Cancelled Post Market |
| 00790842 | BALSULPH OPH ONT 10.0% | BAUSCH & LOMB CANADA INC. | Ointment | SULFACETAMIDE SODIUM 10 % | Cancelled Post Market |
| 00807788 | BLEPHAMIDE | ALLERGAN INC | Drops | SULFACETAMIDE SODIUM 10 %; PREDNISOLONE ACETATE 0.2 % | Cancelled Post Market |
| 00307246 | BLEPHAMIDE S.O.P. | ALLERGAN INC | Ointment | SULFACETAMIDE SODIUM 10 %; PREDNISOLONE ACETATE 0.2 % | Cancelled Post Market |
| 00252522 | CETAMIDE ONT 10% | ALCON CANADA INC | Ointment | SULFACETAMIDE SODIUM 10 % | Cancelled Post Market |
| 00630640 | ODAN-CIDE | ODAN LABORATORIESLTD | Solution | SULFACETAMIDE SODIUM 100 MG; PREDNISOLONE ACETATE 5 MG | Dormant |
| 00622966 | ODAN-SULFACETAMIDE | ODAN LABORATORIESLTD | Solution | SULFACETAMIDE SODIUM 10 % | Dormant |
| 00707465 | OPHTHO-SULF LIQ 10% | ALTIMED PHARMA INC. | Liquid | SULFACETAMIDE SODIUM 10 % | Cancelled Post Market |
| 00762059 | PMS-SULFACETAMIDE SOD OPH SOLN 30% | PHARMASCIENCE INC | Drops | SULFACETAMIDE SODIUM 300 MG | Cancelled Post Market |
| 00838934 | PMS-SULFACETAMIDE SODIUM LIQ 10% | PHARMASCIENCE INC | Liquid | SULFACETAMIDE SODIUM 10 % | Cancelled Post Market |
| 02023814 | PREDNISOLONE/SULFACETAMIDE | PHARMA STULLN INC. | Suspension | SULFACETAMIDE SODIUM 10 %; PREDNISOLONE ACETATE 0.5 % | Dormant |
| 00028053 | SODIUM SULAMYD 10% | SANDOZ CANADA INCORPORATED | Drops | SULFACETAMIDE SODIUM 100 MG | Cancelled Post Market |
| 00028061 | SODIUM SULAMYD OPH DPS 30% | SCHERING-PLOUGH CANADA INC | Drops | SULFACETAMIDE SODIUM 300 MG | Cancelled Post Market |
| 00028347 | SODIUM SULAMYD OPH ONT 10% | SCHERING-PLOUGH CANADA INC | Ointment | SULFACETAMIDE SODIUM 10 % | Cancelled Post Market |
| 01937677 | SULFACET R LOTION | RHONE-POULENC RORER CONSUMER INC. | Lotion | SULFACETAMIDE SODIUM 10 %; SULFUR (SULFUR) 5 % | Cancelled Post Market |
| 02220407 | SULFACET-R | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Lotion | SULFACETAMIDE SODIUM 10 %; SULFUR 5 % | Cancelled Post Market |
| 02023830 | SULFACETAMIDE | PHARMA STULLN INC. | Solution | SULFACETAMIDE SODIUM 10 % | Dormant |
| 00554022 | SULFEX 10% | LABORATOIRES CHARTON LABORATORIES | Liquid | SULFACETAMIDE SODIUM 10 % | Cancelled Post Market |
| 00760048 | VASOSULF OPH SOLN | IOLAB PHARMACEUTICALS | Drops | SULFACETAMIDE SODIUM 150 MG; PHENYLEPHRINE HYDROCHLORIDE 1.25 MG | Cancelled Post Market |
International API supply for SULFACETAMIDE SODIUM
1 valid EDQM Certificates of Suitability from 1 holders. 1 active FDA Drug Master Files.
Request a quote for BLEPH 10 DPS